Pyridostatin is a G-quadruplex ligand that induces conformation changes in telomere-G-quadruplex complexes and stimulates double-stranded DNA breakage; it also alters telomere function. Pyridostatin displays antiviral and anticancer activities. In vitro, this compound decreases synthesis of Epstein-Barr virus-encoded nuclear antigen 1. In cancer cells, pyridostatin suppresses cellular viability and growth.
| Cas No. | 1085412-37-8 |
|---|---|
| Purity | ≥98% |
| Formula | C31H32N8O5 • 5.5 HCl • 5.5 H2O |
| Formula Wt. | 896.3 |
| Synonym | Pyridostatin Trihydrochloride |
| Appearance | Pale yellow powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet | P9870 Info Sheet PDF |
|---|
Marchand A, Granzhan A, Iida K, et al. Ligand-Induced Conformational Changes with Cation Ejection upon Binding to Human Telomeric DNA G-Quadruplexes. J Am Chem Soc. 2015 Jan 21;137(2):750-6. PMID: 25525863.
Murat P, Zhong J, Lekieffre L, et al. G-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation. Nat Chem Biol. 2014 May;10(5):358-64. PMID: 24633353.
McLuckie KI, Di Antonio M, Zecchini H, et al. G-quadruplex DNA as a molecular target for induced synthetic lethality in cancer cells. J Am Chem Soc. 2013 Jul 3;135(26):9640-3. PMID: 23782415.
Müller S, Sanders DA, Di Antonio M, et al. Pyridostatin analogues promote telomere dysfunction and long-term growth inhibition in human cancer cells. Org Biomol Chem. 2012 Aug 28;10(32):6537-46. PMID: 22790277.
